News - BioPharm International



FDA Accepts First Biosimilar Filing

July 24, 2014

Sandoz is first to file for FDA approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009.

Compounding Pharmacy Issues Recall, But Challenges FDA Decision

July 22, 2014

Unique Pharmaceuticals has issued a voluntary recall of sterile compounded preparations, but aired concerns about FDA?s recall demand.

AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes

July 21, 2014

AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.

AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters

July 18, 2014

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

AbbVie to Acquire Shire for $54.7 Billion

July 18, 2014

After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.

Particulate Matter Prompts Baxter's Recall of IV Solutions

July 17, 2014

Baxter investigates root cause of cellulosic fibers and/or plastics in four lots of IV solutions.

Mylan to Acquire Abbott's Non-US Businesses in $5.3 Billion Stock Deal

July 14, 2014

Mylan set to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction.

Shire and AbbVie Discuss Possible Deal

July 14, 2014

New AbbVie proposal results in discussion with Shire about possible $53 billion deal.

Hospira Issues Recall Due to Mold Contamination

July 11, 2014

Puncture in container and overwrap cause leak in intravenous solution, leading to recall by Hospira.



Click here